Hydrocephalus clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 60 years and up
The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.
at UC Davis
Our lead scientists for Hydrocephalus research studies include Kiarash Shahlaie, MD, PhD, FAANS.